Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Leukemia

Free Subscription 24.09.2018 2 Acta Haematol 2 Am J Hematol 2 Ann Hematol 1 Cancer Lett 2 Cancer Res 2 Eur J Haematol 1 J Biol Chem 1 J Clin Oncol 2 Leuk Lymphoma 2 Leuk Res 3 Leukemia 3 N Engl J Med

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Haematol

1. GIONA F, Santopietro M, Menna G, Putti MC, et al
   Real-Life Management of Children and Adolescents with Chronic Myeloid Leukemia: The Italian Experience.
   Acta Haematol. 2018;140:105-111.
   PubMed     Text format     Abstract available
   
   
2. NAESENS L, Devos H, Nollet F, Michaux L, et al
   Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a PICALM-MLLT10 Fusion Gene.
   Acta Haematol. 2018;140:97-104.
   PubMed     Text format     Abstract available
   
   

   
   Am J Hematol

3. BEGNA KH, Ali W, Gangat N, Elliott MA, et al
   A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status.
   Am J Hematol. 2018 Sep 19. doi: 10.1002/ajh.25290.
   PubMed     Text format    
   
   
4. CHRISTOPEIT M, Labopin M, Gorin NC, Saraceni F, et al
   Allogeneic Stem Cell Transplantation following Relapse post Autologous Stem Cell Transplantation in adult patients with Acute Myeloid Leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMT.
   Am J Hematol. 2018 Sep 14. doi: 10.1002/ajh.25285.
   PubMed     Text format     Abstract available
   
   

   
   Ann Hematol

5. VAN DE LOUW A, Lewis AM, Yang Z
   Autopsy findings in patients with acute myeloid leukemia and non-Hodgkin lymphoma in the modern era: a focus on lung pathology and acute respiratory failure.
   Ann Hematol. 2018 Sep 14. pii: 10.1007/s00277-018-3494.
   PubMed     Text format     Abstract available
   
   
6. STEIN AS, Schiller G, Benjamin R, Jia C, et al
   Neurologic adverse events in patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab: management and mitigating factors.
   Ann Hematol. 2018 Sep 20. pii: 10.1007/s00277-018-3497.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Lett

7. WANG Y, Chen H, Chen J, Han M, et al
   The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China.
   Cancer Lett. 2018;438:63-75.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Res

8. 
   Correction: Carbonyl Reductase 1 Offers a Novel Therapeutic Target to Enhance Leukemia Treatment by Arsenic Trioxide.
   Cancer Res. 2018;78:5464.
   PubMed     Text format    
   
   
9. SOEGAARD SH, Rostgaard K, Skogstrand K, Wiemels JL, et al
   Neonatal Inflammatory Markers Are Associated with Childhood B-cell Precursor Acute Lymphoblastic Leukemia.
   Cancer Res. 2018;78:5458-5463.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Haematol

10. REISER M, Dorfel S, Hensel M, Hoesl M, et al
    Rituximab in combination with chemotherapy for the treatment of chronic lymphocytic leukaemia in clinical practice.
    Eur J Haematol. 2018;100:455-464.
    PubMed     Text format     Abstract available
    
    
11. KURT H, Jorgensen JL, Amin HM, Patel KP, et al
    Chronic lymphoproliferative disorder of NK-cells: A single-institution review with emphasis on relative utility of multimodality diagnostic tools.
    Eur J Haematol. 2018;100:444-454.
    PubMed     Text format     Abstract available
    
    

    
    J Biol Chem

12. WU W, Hatterschide J, Syu YC, Cantara WA, et al
    Human T-cell leukemia virus type 1 Gag domains have distinct RNA-binding specificities with implications for RNA packaging and dimerization.
    J Biol Chem. 2018 Sep 14. pii: RA118.005531. doi: 10.1074/jbc.RA118.005531.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

13. BASSAN R, Bourquin JP, DeAngelo DJ, Chiaretti S, et al
    New Approaches to the Management of Adult Acute Lymphoblastic Leukemia.
    J Clin Oncol. 2018 Sep 21:JCO2017773648. doi: 10.1200/JCO.2017.77.3648.
    PubMed     Text format     Abstract available
    
    

    
    Leuk Lymphoma

14. D'ARENA G, Seneca E, Migliaccio I, De Feo V, et al
    Oxidative stress in chronic lymphocytic leukemia: still a matter of debate.
    Leuk Lymphoma. 2018 Sep 20:1-9. doi: 10.1080/10428194.2018.1509317.
    PubMed     Text format     Abstract available
    
    
15. MCMAHON CM, Perl AE
    Management of primary refractory acute myeloid leukemia in the era of targeted therapies.
    Leuk Lymphoma. 2018 Sep 20:1-14. doi: 10.1080/10428194.2018.1504937.
    PubMed     Text format     Abstract available
    
    

    
    Leuk Res

16. SAVOIE ML, Bence-Bruckler I, Huebsch LB, Lalancette M, et al
    Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era.
    Leuk Res. 2018;73:67-75.
    PubMed     Text format     Abstract available
    
    
17. TALATI C, Sweet K
    Recently approved therapies in acute myeloid leukemia: A complex treatment landscape.
    Leuk Res. 2018;73:58-66.
    PubMed     Text format     Abstract available
    
    

    
    Leukemia

18. DEGRYSE S, de Bock CE, Demeyer S, Govaerts I, et al
    Correction: Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia.
    Leukemia. 2018 Sep 19. pii: 10.1038/s41375-018-0241.
    PubMed     Text format     Abstract available
    
    
19. MAEKAWA T, Osawa Y, Izumi T, Nagao S, et al
    Correction: Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis.
    Leukemia. 2018 Sep 19. pii: 10.1038/s41375-018-0237.
    PubMed     Text format     Abstract available
    
    
20. PRIETO C, Lopez-Millan B, Roca-Ho H, Stam RW, et al
    Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL.
    Leukemia. 2018 Sep 14. pii: 10.1038/s41375-018-0236.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

21. 
    Ivosidenib in IDH1-Mutated Acute Myeloid Leukemia.
    N Engl J Med. 2018;379:1186.
    PubMed     Text format    
    
    
22. IYASERE CA, Takvorian RW, Simeone FJ, Siegele BJ, et al
    Case 28-2018: A 39-Year-Old Man with Epistaxis, Pain and Erythema of the Forearm, and Pancytopenia.
    N Engl J Med. 2018;379:1072-1081.
    PubMed     Text format    
    
    
23. DUNCAVAGE EJ, Jacoby MA, Chang GS, Miller CA, et al
    Mutation Clearance after Transplantation for Myelodysplastic Syndrome.
    N Engl J Med. 2018;379:1028-1041.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: